[Patient management during the recovery period following dissociate anesthesia].
D000293:Adolescent; D000328:Adult; D000768:Anesthesia, General; D000778:Anesthetics, Dissociative; D000932:Antiemetics / Q000627:therapeutic use; D001828:Body Image / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D004325:Dreams; D005602:France; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007362:Intensive Care Units; D007649:Ketamine / Q000009:adverse effects*; D010640:Phenothiazines / Q000627:therapeutic use; D011182:Postoperative Care; D011398:Promethazine / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced; D013874:Thiopental / Q000627:therapeutic use; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000778:Anesthetics, Dissociative; D000932:Antiemetics; D010640:Phenothiazines; D007649:Ketamine; D012110:Reserpine; D011398:Promethazine; D013874:Thiopental; D002746:Chlorpromazine
Conduite à tenir pendant la période de récupération de l'anesthésie dissociative